Portland health startup MedRhythms grows pipeline with new clinical trial, scientific board

MedRhythms Inc., a Portland health technology startup, is beginning a new clinical trial of the company’s digital therapeutic device for walking impairments related to Parkinson’s disease.

The multisite study will be conducted through a collaboration with Boston University and a leading hospital, and will evaluate the efficacy of the device when used at home, according to a news release.

MedRhythms, launched in 2016, is developing systems with clinical-grade sensors, music and artificial intelligence to measure and improve walking for people with neurological injuries or diseases. Read more

Related Posts

Maine’s startup ‘mojo’ highlighted in national ranking

As a place to start a business, Maine’s “mojo” is going strong, as shown in a new national ranking released Tuesday by WalletHub,...

19 January 2023

Maine CDC Director Nirav Shah to join U.S. CDC leadership

Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, has been appointed principal deputy director at the...

13 January 2023

$5.6M in state funding to support Maine startups, entrepreneurs

Sixteen Maine organizations helping startups and entrepreneurs will share $5.6 million in state funding from the Pandemic Recovery for an Innovative Maine...

11 January 2023